Keyphrases
Cost-effectiveness
100%
Older Men
100%
Clinical Fractures
100%
Osteoporosis Treatment
100%
Bone Densitometry
100%
Incident Fractures
100%
Life-years Gained
75%
Quality-adjusted Life Years
75%
Oral Bisphosphonates
75%
Treatment Strategy
50%
Osteoporotic Fractures
50%
Osteoporosis
50%
Bone Mineral Density
50%
Densitometry
50%
Fracture Rate
50%
Aged 80 Years and over
50%
Lifetime Cost
50%
Disutility
50%
Bisphosphonate Therapy
50%
Follow-up Treatment
50%
Meta-analysis
25%
Femoral Neck
25%
Population-based
25%
Willingness to Pay
25%
Fracture Reduction
25%
Cost Reduction
25%
Medication Adherence
25%
Age-specific
25%
Bone Fracture
25%
Elderly People
25%
T-score
25%
Association Strength
25%
Societal Perspective
25%
Markov Microsimulation Model
25%
Rochester Epidemiology Project
25%
White People
25%
Cost-based
25%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
Osteoporosis
100%
Bone Densitometry
100%
Bisphosphonate
50%
Quality Adjusted Life Year
50%
Lifespan
37%
Oral
37%
Fragility Fracture
25%
Bone Density
25%
Densitometry
25%
Cohort Effect
12%
Femoral Neck
12%
Meta-Analysis
12%
Medication Compliance
12%
Fracture Reduction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
100%
Fragility Fracture
50%